Viking Therapeutics, Inc. VKTX
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Joon Lee | Truist Financial | 25.94 $ | 75 $ | 49.06 % | 28/04/2025 |
| Biren Amin | Piper Sandler | 52.94 $ | 74 $ | 21.06 % | 02/12/2024 |
| Yale Jen | Laidlaw | 63.14 $ | 110 $ | 46.86 % | 04/11/2024 |
| Roger Song | Jefferies | 63.14 $ | 110 $ | 46.86 % | 04/11/2024 |
| Michael Ulz | Morgan Stanley | 47.39 $ | 105 $ | 57.61 % | 27/06/2024 |
| Joseph Pantginis | H.C. Wainwright | 52.12 $ | 90 $ | 37.88 % | 25/06/2024 |
| Steve Seedhouse | Raymond James | 69.06 $ | 116 $ | 46.94 % | 16/05/2024 |
| Joon Lee | Truist Financial | 69.525 $ | 120 $ | 50.48 % | 16/05/2024 |
| Jay Olson | Oppenheimer | 80.83 $ | 138 $ | 57.17 % | 26/03/2024 |
| Justin Zelin | BTIG | 83.98 $ | 125 $ | 41.02 % | 26/03/2024 |
| Samimy Annabel | Stifel Nicolaus | 83.87 $ | 95 $ | 11.13 % | 26/03/2024 |
| Justin Zelin | BTIG | 62.56 $ | 100 $ | 37.44 % | 15/03/2024 |
| Maxim Maxim | Maxim Group | 8.45 $ | 15 $ | 6.55 % | 24/12/2022 |
| Justin Zelin | BTIG | 6.721 $ | 20 $ | 13.28 % | 19/12/2022 |
| Joseph Pantginis | H.C. Wainwright | 6.365 $ | 21 $ | 14.64 % | 19/12/2022 |